XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic...
116 insider purchases on record · latest filing 2025-12-08.
Insiders have also filed 242 sale transactions at XOMA.